Mesa Laboratories, Inc.
MLAB
$103.99
$4.204.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.97M | -249.44M | -245.65M | -250.31M | -254.25M |
| Total Depreciation and Amortization | 24.53M | 23.33M | 26.88M | 28.91M | 31.57M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.35M | 267.37M | 256.78M | 259.27M | 260.83M |
| Change in Net Operating Assets | 6.90M | 5.78M | 2.11M | 6.76M | 5.97M |
| Cash from Operations | 46.81M | 47.03M | 40.12M | 44.63M | 44.13M |
| Capital Expenditure | -4.25M | -4.03M | -4.34M | -3.19M | -2.57M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 961.00K | -78.74M | -78.74M | -78.74M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -250.00K | -- | -- | -- | -- |
| Cash from Investing | -4.50M | -3.07M | -83.08M | -81.93M | -81.31M |
| Total Debt Issued | 73.47M | 73.47M | 144.47M | 144.47M | 71.00M |
| Total Debt Repaid | -115.81M | -109.37M | -108.63M | -106.19M | -33.50M |
| Issuance of Common Stock | 2.64M | 358.00K | 358.00K | 358.00K | 358.00K |
| Repurchase of Common Stock | -887.00K | -728.00K | -728.00K | -728.00K | -728.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.47M | -3.46M | -3.46M | -3.45M | -3.45M |
| Other Financing Activities | -452.00K | -1.51M | -1.82M | -1.21M | -847.00K |
| Cash from Financing | -44.51M | -41.25M | 30.20M | 33.25M | 32.84M |
| Foreign Exchange rate Adjustments | 1.31M | 21.00K | 1.48M | 150.00K | -359.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -893.00K | 2.73M | -11.28M | -3.90M | -4.70M |